Efficacy of nanoTCEs in vivo. (A) Tumor progression and (B) Kaplan-Meier survival comparison between mice treated with Isotype/CD3 (grey; n = 5) or CD33/CD3 nanoTCEs (green; n = 5) (IMAGE)

Impact Journals LLC

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.